These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31953865)

  • 1. Indole Alleviates Diet-Induced Hepatic Steatosis and Inflammation in a Manner Involving Myeloid Cell 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3.
    Ma L; Li H; Hu J; Zheng J; Zhou J; Botchlett R; Matthews D; Zeng T; Chen L; Xiao X; Athrey G; Threadgill DW; Li Q; Glaser S; Francis H; Meng F; Li Q; Alpini G; Wu C
    Hepatology; 2020 Oct; 72(4):1191-1203. PubMed ID: 31953865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive transfer of
    Guo X; Zhu B; Xu H; Li H; Jiang B; Wang Y; Zheng B; Glaser S; Alpini G; Wu C
    Liver Res; 2020 Sep; 4(3):136-144. PubMed ID: 34336366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Garlic-derived exosomes regulate PFKFB3 expression to relieve liver dysfunction in high-fat diet-fed mice via macrophage-hepatocyte crosstalk.
    Liu J; Li W; Bian Y; Jiang X; Zhu F; Yin F; Yin L; Song X; Guo H; Liu J
    Phytomedicine; 2023 Apr; 112():154679. PubMed ID: 36791628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indole alleviates nonalcoholic fatty liver disease in an ACE2-dependent manner.
    Gao Y; Chen Q; Yang S; Cao J; Li F; Li R; Wu Z; Wang Y; Yuan L
    FASEB J; 2024 Sep; 38(18):e70061. PubMed ID: 39305120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity.
    Cai Y; Li H; Liu M; Pei Y; Zheng J; Zhou J; Luo X; Huang W; Ma L; Yang Q; Guo S; Xiao X; Li Q; Zeng T; Meng F; Francis H; Glaser S; Chen L; Huo Y; Alpini G; Wu C
    Hepatology; 2018 Jul; 68(1):48-61. PubMed ID: 29315766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress.
    Ji Y; Gao Y; Chen H; Yin Y; Zhang W
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31484323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity.
    Woo SL; Xu H; Li H; Zhao Y; Hu X; Zhao J; Guo X; Guo T; Botchlett R; Qi T; Pei Y; Zheng J; Xu Y; An X; Chen L; Chen L; Li Q; Xiao X; Huo Y; Wu C
    PLoS One; 2014; 9(3):e91111. PubMed ID: 24638078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose tissue inflammation and systemic insulin resistance in mice with diet-induced obesity is possibly associated with disruption of PFKFB3 in hematopoietic cells.
    Zhu B; Guo X; Xu H; Jiang B; Li H; Wang Y; Yin Q; Zhou T; Cai JJ; Glaser S; Meng F; Francis H; Alpini G; Wu C
    Lab Invest; 2021 Mar; 101(3):328-340. PubMed ID: 33462362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice.
    Ding Y; Yanagi K; Yang F; Callaway E; Cheng C; Hensel ME; Menon R; Alaniz RC; Lee K; Jayaraman A
    Elife; 2024 Feb; 12():. PubMed ID: 38412016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
    Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
    Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.
    Luo X; Li H; Ma L; Zhou J; Guo X; Woo SL; Pei Y; Knight LR; Deveau M; Chen Y; Qian X; Xiao X; Li Q; Chen X; Huo Y; McDaniel K; Francis H; Glaser S; Meng F; Alpini G; Wu C
    Gastroenterology; 2018 Dec; 155(6):1971-1984.e4. PubMed ID: 30213555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
    Wu L; Liu Y; Zhao Y; Li M; Guo L
    Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD.
    Gehrke N; Biedenbach J; Huber Y; Straub BK; Galle PR; Simon P; Schattenberg JM
    Sci Rep; 2019 Mar; 9(1):4007. PubMed ID: 30850619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation by Tetrahydrocurcumin of Adiposity and Hepatic Steatosis in Mice with High-Fat-Diet-Induced Obesity.
    Pan MH; Chen JW; Kong ZL; Wu JC; Ho CT; Lai CS
    J Agric Food Chem; 2018 Dec; 66(48):12685-12695. PubMed ID: 30415544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-substituted phenylbenzamides of the niclosamide chemotype attenuate obesity related changes in high fat diet fed mice.
    Bhagat HA; Compton SA; Musso DL; Laudeman CP; Jackson KMP; Yi NY; Nierobisz LS; Forsberg L; Brenman JE; Sexton JZ
    PLoS One; 2018; 13(10):e0204605. PubMed ID: 30359371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
    Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y
    Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.
    Takahara I; Akazawa Y; Tabuchi M; Matsuda K; Miyaaki H; Kido Y; Kanda Y; Taura N; Ohnita K; Takeshima F; Sakai Y; Eguchi S; Nakashima M; Nakao K
    PLoS One; 2017; 12(3):e0170591. PubMed ID: 28278289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.